1. Home
  2. RLAY vs USNA Comparison

RLAY vs USNA Comparison

Compare RLAY & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • USNA
  • Stock Information
  • Founded
  • RLAY 2015
  • USNA 1992
  • Country
  • RLAY United States
  • USNA United States
  • Employees
  • RLAY N/A
  • USNA N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • USNA Medicinal Chemicals and Botanical Products
  • Sector
  • RLAY Health Care
  • USNA Health Care
  • Exchange
  • RLAY Nasdaq
  • USNA Nasdaq
  • Market Cap
  • RLAY 620.4M
  • USNA 648.2M
  • IPO Year
  • RLAY 2020
  • USNA 1996
  • Fundamental
  • Price
  • RLAY $2.62
  • USNA $26.99
  • Analyst Decision
  • RLAY Strong Buy
  • USNA Hold
  • Analyst Count
  • RLAY 10
  • USNA 1
  • Target Price
  • RLAY $19.33
  • USNA $36.00
  • AVG Volume (30 Days)
  • RLAY 2.5M
  • USNA 231.6K
  • Earning Date
  • RLAY 05-01-2025
  • USNA 04-29-2025
  • Dividend Yield
  • RLAY N/A
  • USNA N/A
  • EPS Growth
  • RLAY N/A
  • USNA N/A
  • EPS
  • RLAY N/A
  • USNA 2.19
  • Revenue
  • RLAY $10,007,000.00
  • USNA $854,503,000.00
  • Revenue This Year
  • RLAY N/A
  • USNA $12.75
  • Revenue Next Year
  • RLAY $544.28
  • USNA $9.19
  • P/E Ratio
  • RLAY N/A
  • USNA $12.68
  • Revenue Growth
  • RLAY N/A
  • USNA N/A
  • 52 Week Low
  • RLAY $2.45
  • USNA $26.19
  • 52 Week High
  • RLAY $10.72
  • USNA $49.78
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 32.07
  • USNA 37.18
  • Support Level
  • RLAY $3.05
  • USNA $26.19
  • Resistance Level
  • RLAY $3.08
  • USNA $28.18
  • Average True Range (ATR)
  • RLAY 0.25
  • USNA 1.05
  • MACD
  • RLAY -0.04
  • USNA -0.07
  • Stochastic Oscillator
  • RLAY 11.64
  • USNA 11.61

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.

Share on Social Networks: